Difficulty: Medium
Average Score: 77%
Practice
Suzanne is pregnant and has tested HIV positive. Which antiretroviral drug should be avoided in women who are pregnant?
Correct answer
D
Rationale
Efavirenz should be avoided in pregnant women, especially in the first trimester, due to early concerns about teratogenicity (e.g., neural tube defects) from animal studies and case reports. Though recent data (Tsepamo, 2018) show a low risk (0.05% vs. 0.02% baseline), NIH and WHO guidelines favor safer alternatives like dolutegravir. Lopinavir/ritonavir (A, C combined) is used in pregnancy, though less now due to tolerability; it's not contraindicated. Zidovudine is safe and foundational for MTCT prevention (ACTG 076). Ritonavir as a booster is acceptable in combinations. Efavirenz's historical risk profile, despite evolving evidence, drives its avoidance in favor of drugs with established safety, making D the conservative, guideline-aligned choice.